title: [Body dysmorphic disorder: clinical aspects, nosological dimensions and controversies with anorexia nervosa].
abstract: There is strong evidence about the co-existence of body dysmorphic disorder (BDD) and eating disorders (ED), particularly with anorexia nervosa (AN). An exhaustive review of the specialised literature regarding these disorders was carried out. The results show that their co-occurrence implies a more complex diagnosis and treatment, a more severe clinical symptomatology and a worse prognosis and outcome. Both disorders display common similarities, differences and comorbidities, which allow authors to classify them in different nosological spectra (somatomorphic, anxious, obsessive-compulsive, affective and psychotic). Their crossover involves higher levels of body dissatisfaction and body image distortion, depression, suicidal tendency, personality disorders, substance use/abuse, obsessive-compulsive disorder, social phobia, alexithymia and childhood abuse or neglect background. Treatment including cognitive-behavioral psychotherapy and selective reuptake serotonin inhibitors are effective for both, BDD and ED; nevertheless, plastic surgery could exacerbate BDD. Clinical traits of BDD must be systematically detected in patients suffering from ED and vice versa.
authors.forename: Rosa
authors.initials: R
authors.lastname: Behar
authors.forename: Marcelo
authors.initials: M
authors.lastname: Arancibia
authors.forename: Cristóbal
authors.initials: C
authors.lastname: Heitzer
authors.forename: Nicolás
authors.initials: N
authors.lastname: Meza
mesh_terms: D000856:Anorexia Nervosa / Q000523:psychology* / Q000628:therapy; D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D057215:Body Dysmorphic Disorders / Q000523:psychology* / Q000628:therapy; D015928:Cognitive Behavioral Therapy; D015897:Comorbidity; D006801:Humans; D017367:Selective Serotonin Reuptake Inhibitors
chemical_list: D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D017367:Selective Serotonin Reuptake Inhibitors